Total Payments
$1,445
2024 Payments
$528.14
Companies
10
Transactions
69
Medicare Patients
771
Medicare Billing
$103,521
Payment Breakdown by Category
Food & Beverage$1,440 (99.7%)
Education$4.22 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,440 | 68 | 99.7% |
| Education | $4.22 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $458.90 | 30 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $280.78 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $223.28 | 7 | $0 (2024) |
| Amgen Inc. | $221.68 | 14 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $123.07 | 1 | $0 (2022) |
| Ardelyx, Inc. | $45.27 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $37.73 | 2 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $31.36 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $17.30 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $528.14 | 25 | AstraZeneca Pharmaceuticals LP ($172.31) |
| 2023 | $302.84 | 22 | Fresenius USA Marketing, Inc. ($168.28) |
| 2022 | $359.07 | 8 | Bayer HealthCare Pharmaceuticals Inc. ($174.17) |
| 2021 | $254.52 | 14 | Fresenius USA Marketing, Inc. ($88.13) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/17/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/17/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/30/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/21/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/02/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $5.20 | General |
| 04/22/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/21/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $18.86 | General |
| 03/14/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $21.50 | General |
| 03/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/21/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Cardio-renal | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), LOKELMA | Food and Beverage | In-kind items and services | $101.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $32.97 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 187 | 234 | $101,114 | $29,606 |
| 2022 | 4 | 158 | 188 | $68,508 | $16,573 |
| 2021 | 5 | 240 | 289 | $98,182 | $32,878 |
| 2020 | 5 | 186 | 224 | $76,365 | $24,464 |
Total Patients
771
Total Services
935
Medicare Billing
$103,521
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 31 | 43 | $33,970 | $11,434 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 138 | $41,124 | $9,970 | 24.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 21 | 33 | $21,780 | $7,255 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $4,240 | $947.05 | 22.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 24 | 31 | $20,980 | $6,842 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 103 | $31,132 | $5,466 | 17.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 14 | 19 | $8,926 | $2,848 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 35 | $7,470 | $1,416 | 19.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 35 | 51 | $34,312 | $11,774 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 85 | $25,818 | $8,553 | 33.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 94 | 111 | $23,853 | $7,739 | 32.4% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 20 | 28 | $13,002 | $4,481 | 34.5% |
| 98968 | Telephone assessment and management service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 14 | $1,197 | $331.32 | 27.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 31 | 47 | $26,132 | $8,612 | 33.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 80 | $14,320 | $4,470 | 31.2% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 22 | 30 | $12,960 | $4,224 | 32.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 53 | $13,727 | $4,046 | 29.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 13 | 14 | $9,226 | $3,111 | 33.7% |
About Melissa Clark, ARNP
Melissa Clark, ARNP is a Gerontology healthcare provider based in Concord, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2017. The National Provider Identifier (NPI) number assigned to this provider is 1639681000.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Clark, ARNP has received a total of $1,445 in payments from pharmaceutical and medical device companies, with $528.14 received in 2024. These payments were reported across 69 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,440).
As a Medicare-enrolled provider, Clark has provided services to 771 Medicare beneficiaries, totaling 935 services with total Medicare billing of $103,521. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Gerontology
- Location Concord, CA
- Active Since 10/25/2017
- Last Updated 12/19/2018
- Taxonomy Code 363LG0600X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639681000
Products in Payments
- Velphoro (Drug) $398.57
- Kerendia (Drug) $280.78
- FARXIGA (Drug) $172.31
- KRYSTEXXA (Biological) $142.70
- LifeVest (Device) $123.07
- Parsabiv (Drug) $83.74
- LOKELMA (Drug) $50.97
- IBSRELA (Drug) $45.27
- Aranesp (Biological) $32.97
- ACTHAR (Biological) $31.36
- JYNARQUE (Drug) $17.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gerontology Doctors in Concord
Mr. Richard Lapage, Aprn, APRN
Gerontology — Payments: $3,491
Gerontology $3,491
Maria Obraztsova, Np, NP
Gerontology — Payments: $2,182
Gerontology $2,182
Delana Lucas, Agpcnp-Bc, AGPCNP-BC
Gerontology — Payments: $523.20
Gerontology $523.20
Kim Eldredge, Np, NP
Gerontology — Payments: $321.89
Gerontology $321.89
Bryson Kennedy
Gerontology — Payments: $171.76
Gerontology $171.76
Julie Henderson, Msn, Aprn, Agcns, MSN, APRN, AGCNS
Gerontology — Payments: $15.71
Gerontology $15.71